Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo

References

• GoodenbergerMLJenkinsRBGenetics of adult gliomaCancer Genet20122051261362123238284
   PubMed Web of Science ®Google Scholar
• LeuSvon FeltenSFrankSBoulayJLMarianiLIDH mutation is associated with higher risk of malignant transformation in low-grade gliomaJ Neurooncol2016127236337226780338
   PubMed Web of Science ®Google Scholar
• KumarAAhujaAAliJBabootaSCurcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cellsDrug Deliv201623121422924825490
   PubMed Web of Science ®Google Scholar
• Kaidar-PersonODarawsheFTzuk-ShinaTEranAThe clinical significance of ependymal enhancement at presentation in patients with malignant gliomaRambam Maimonides Med J201564
   Google Scholar
• SuryadevaraCMVerlaTSanchez-PerezLImmunotherapy for malignant gliomaSurg Neurol Int20156suppl 1S68S7725722935
   PubMedGoogle Scholar
• HarbilasDMartineauLCHarrisCSEvaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part IICan J Physiol Pharmacol200987647949219526043
   PubMed Web of Science ®Google Scholar
• AbbasSYBasyouniWMEl-BayoukKAMNew biguanides as anti-diabetic agents part I: synthesis and evaluation of 1-substituted biguanide derivatives as anti-diabetic agents of type II diabetes insulin resistantDrug Res20176710557563
   Web of Science ®Google Scholar
• VelezJPanRLeeJTBiguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transportOncotarget2016732514355144927283492
   PubMedGoogle Scholar
• SongISHanJLeeHKMetformin as an anticancer drug: a commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanidesJ Diabetes Investig201565516518
   PubMed Web of Science ®Google Scholar
• BourronODavalMHainaultIBiguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinaseDiabetologia201053476877820043143
   PubMed Web of Science ®Google Scholar
• BridgesHRSirvioVAAgipANHirstJMolecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinaseBMC Biol2016146527506389
   PubMed Web of Science ®Google Scholar
• LamichhaneSBastolaTPariyarRROS production and ERK activity are involved in the effects of d-beta-hydroxybutyrate and metformin in a glucose deficient conditionInt J Mol Sci2017183E67428335557
   PubMed Web of Science ®Google Scholar
• HouXBLiTHRenZPLiuYCombination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: a reactive oxygen species and P-p38 mediated mechanismBiomed Pharmacother2016841575158427825799
   PubMed Web of Science ®Google Scholar
• SaekiKWatanabeMTsuboiMAnti-tumour effect of metformin in canine mammary gland tumour cellsVet J2015205229730425981932
   PubMed Web of Science ®Google Scholar
• FimognariFLCorsonelloAPastorelliRAntonelli IncalziROlder age and phenformin therapy: a dangerous associationIntern Emerg Med20083440140318415028
   PubMed Web of Science ®Google Scholar
• OrecchioniSReggianiFTalaricoGThe biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cellsInt J Cancer20151366E534E54425196138
   PubMed Web of Science ®Google Scholar
• MengSCaoJHeQMetformin activates AMP-activated protein kinase by promoting formation of the alphabetagamma heterotrimeric complexJ Biol Chem201529063793380225538235
   PubMed Web of Science ®Google Scholar
• KirpichnikovDMcFarlaneSISowersJRMetformin: an updateAnn Intern Med20021371253312093242
   PubMed Web of Science ®Google Scholar
• JiaDKoonceNAGriffinRJJacksonCCorryPMPrevention and mitigation of acute death of mice after abdominal irradiation by the antioxidant N-acetyl-cysteine (NAC)Radiat Res2010173557958920426657
   PubMed Web of Science ®Google Scholar
• De SouzaAKhawajaKIMasudFSaifMWMetformin and pancreatic cancer: is there a role?Cancer Chemother Pharmacol201677223524226740120
   PubMed Web of Science ®Google Scholar
• ZhangHHGuoXLCombinational strategies of metformin and chemotherapy in cancersCancer Chemother Pharmacol2016781132627118574
   PubMed Web of Science ®Google Scholar
• MenaminUCCardwellCRHughesCMMurrayLMMetformin use and survival from lung cancer: a population-based cohort studyLung Cancer201694353926973204
   PubMed Web of Science ®Google Scholar
• MedairosRAClarkJHoloubekSMetformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancerJ Thorac Cardiovasc Surg2016152155.e161.e127157918
   PubMed Web of Science ®Google Scholar
• NieZZhuHGuMReduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysisPharm Biol201654112636264227159666
   PubMed Web of Science ®Google Scholar
• RidlerCTherapy: metformin protective against colorectal cancer?Nat Rev Gastroenterol Hepatol2016135250
   Google Scholar
• LiuFYanLWangZMetformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: a systematic review and meta-analysisOncotarget201789160171602627926481
   PubMedGoogle Scholar
• Casadei GardiniAFaloppiLDe MatteisSMetformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: validation study and biological rationaleEur J Cancer20178610611428985579
   PubMed Web of Science ®Google Scholar
• ShiYHeZJiaZXuCInhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivoMol Med Rep20161442921292827499118
   PubMed Web of Science ®Google Scholar
• ZhangHHZhangYChengYNMetformin in combination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivoMol Carcinog2018571445628833603
   PubMed Web of Science ®Google Scholar
• KimEHLeeJHOhYInhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metforminNeuro Oncol201719219720727571886
   PubMed Web of Science ®Google Scholar
• ZhaoBWangXZhengJWangHLiuJEffects of metformin treatment on glioma-induced brain edemaAm J Transl Res2016883351336327648126
   PubMed Web of Science ®Google Scholar
• YangSHLiSLuGMetformin treatment reduces temozolomide resistance of glioblastoma cellsOncotarget2016748787877880327791206
   PubMedGoogle Scholar
• LeidgensVProskeJRauerLStattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylationOncotarget2017858250826328030813
   PubMedGoogle Scholar
• JiangWFinnissSCazacuSRepurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastomaOncotarget2016735564565647027486821
   PubMedGoogle Scholar
• HanGGongHWangYGuoSLiuKAMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cellCancer Biol Ther2015161778725456211
   PubMed Web of Science ®Google Scholar
• MukhopadhyaySChatterjeeAKoganDPatelDFosterDA5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cellsCell Cycle201514203331333926323019
   PubMed Web of Science ®Google Scholar
• ChengGLanza-JacobySMetformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: role of NOX4Biochem Biophys Res Commun20154651414626225747
   PubMed Web of Science ®Google Scholar